EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
about
Human papillomavirus-associated cancers: A growing global problemHistorical review of the causes of cancerRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerEUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infectionMaturation of the Human Papillomavirus 16 CapsidEurogin 2016 Roadmap: how HPV knowledge is changing screening practice.Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapyPrevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populationsEvolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a "fundamental cause" perspective.Factors associated with genital human papillomavirus infection among adult females in the United States, NHANES 2007-2010Differential Gene Expression Landscape of Co-Existing Cervical Pre-Cancer Lesions Using RNA-seqA second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA resultsVulval cancer and HPV vaccination in recurrent diseaseReduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers.Molecular genotyping of human papillomavirus l1 gene in low-risk and high-risk populations in Bangkok.Recent Insights into the Control of Human Papillomavirus (HPV) Genome Stability, Loss, and Degradation.Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.Adverse Psychosexual Impact Related to the Treatment of Genital Warts and Cervical Intraepithelial NeoplasiaFrench multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patientsSerial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections.Excessive adiposity, metabolic health, and risks for genital human papillomavirus infection in adult women: a population-based cross-sectional study.Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.Monitoring human papillomavirus prevalence in urine samples: a review.Knowledge about HPV and Screening of Cervical Cancer among Women from the Metropolitan Region of Natal, Brazil.Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.Prevalence of human papillomavirus type 58 in women with or without cervical lesions in northeast Brazil.Epidemiology of anal HPV infection in high-risk men attending a sexually transmitted infection clinic in Puerto Rico.An exploratory study of the informational and psychosocial needs of patients with human papillomavirus-associated oropharyngeal cancerRNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection.Male and couple fertility impairment due to HPV-DNA sperm infection: update on molecular mechanism and clinical impact--systematic review.Recent advances in understanding and preventing human papillomavirus-related disease.High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.Current recommendations for cervical cancer screening: do they render the annual pelvic examination obsolete?Cervical cancer screening: on the way to a shift from cytology to full molecular screening.Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review.Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review.Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients.Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
P2860
Q26748962-1C7EB1B0-4E15-4196-B7B0-ED0199E5D9FEQ26767036-19C29C2A-8187-45DA-9B5A-2A4672EE3D12Q26782255-584D5390-88D2-4679-ADCD-DD10E476BBB4Q27010432-D9B42619-BAD5-4CBA-80E5-3EBFAE5F01BFQ27684947-1A4EA036-C242-4768-AE8A-165EA9CFDD05Q30239987-C9349A10-7764-4EFE-A864-11696CF667F2Q30241076-B8C3C29D-2858-4DF5-83B2-2F3E39CD9CB8Q30317259-0EC2D7BB-518C-4939-A1B6-9FBCADD4F586Q33599099-F1ADE3F3-6FAA-496E-8D86-87C71EF6CD73Q33876833-F3439B09-1C56-4600-934E-9F9CE024DF64Q34076672-4D0F66E1-DE1E-4E5D-A90A-79BBBA7B0D05Q34574451-72DCF250-B06B-4207-A8BC-919237A19D2CQ34703399-A8667DBD-DB98-4AD0-894B-AEE61A811B57Q34733896-94F9330E-C34F-47CA-98A6-0BD0FA43124FQ34736045-131C2AE0-6981-4839-B8D3-B67BA7EC3E1FQ34935007-1DCD57D5-F282-471E-A814-D25114BC1ED8Q35174433-4B9703C3-0720-4F84-8E89-0B67CC3704F7Q35195553-648BF039-A012-4AA4-8E19-309668AAEC1AQ35475603-AB0C0DED-7D3A-41EA-B85E-678138B49293Q35623700-2941B499-48CF-4BED-AE57-5A8DA3460DBAQ36009950-14849505-ED13-4FDE-9B2E-52EBAB00729AQ36023925-5A4CD6A3-9B30-4211-8551-F4F5B2BF60A0Q36115134-6B254A13-762E-42F8-A95F-F14BC4276A40Q36414150-939E29B3-DA90-43C2-9CB5-2135BD2C1607Q36694308-91FD3D05-338D-4016-BBEC-313B45C10B60Q36773356-B5DBEE9A-C500-46D8-8588-A2EE46F8170CQ36794559-0FBFBF1D-B8FD-4969-B57D-0901D52FDB65Q37403541-BB25ADF8-3549-4171-911B-3F5DE7E9EF68Q37439183-2F7C397D-6019-401A-B2EA-EACB384E8B7BQ37661595-32826BC1-0F76-40F2-8A40-54D16722888DQ37692493-7890BAF2-8001-46ED-BA9D-ED42C9F843B9Q37695921-DF61283A-6650-4750-9B22-976360890709Q37709706-1CCC91AF-DD75-4211-BA47-ED35B1507193Q38036140-9321C9E1-7A4B-4390-8AC5-01DE17E4E099Q38074769-59607829-35AF-441E-89F1-CEBBF50C5AE3Q38180277-13C8DBC5-9AD7-4B21-9767-F802650E067BQ38231273-48C48E8D-0C2C-4D4B-B06C-1F4DCA8D75DAQ38707755-953169DB-7126-4785-94B0-9B3CD6B0C0EDQ38858208-E2DB843D-9F15-4766-B6BF-1EEC1018FC33Q38859808-6A246848-FD25-417B-B650-34C8C059ACC1
P2860
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
@ast
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
@en
type
label
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
@ast
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
@en
prefLabel
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
@ast
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
@en
P2093
P2860
P50
P356
P1476
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
@en
P2093
Anna Giuliano
Charles Lacey
Guglielmo Ronco
Jacob Bornstein
Joel Palefsky
Joseph Monsonego
Laurent Abramowitz
Lynnette Denny
Marc Arbyn
Mario Sideri
P2860
P304
P356
10.1002/IJC.27650
P577
2012-07-02T00:00:00Z